PlainRecalls
FDA Drug Low Class III Terminated

Valsartan Tablets USP, 320 mg, 90 tablet, Rx Only, Manufactured by: Jubilant Generics Ltd. Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-363-90

Reported: June 13, 2018 Initiated: May 25, 2018 #D-0876-2018

Product Description

Valsartan Tablets USP, 320 mg, 90 tablet, Rx Only, Manufactured by: Jubilant Generics Ltd. Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-363-90

Reason for Recall

Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).

Details

Units Affected
2,328 bottles (Lot VR417065A) and 2,352 bottles (Lot VR417066A)
Distribution
IN, MI, MS, NC, NJ, NY and OH
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Valsartan Tablets USP, 320 mg, 90 tablet, Rx Only, Manufactured by: Jubilant Generics Ltd. Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-363-90. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 2,328 bottles (Lot VR417065A) and 2,352 bottles (Lot VR417066A).
Why was this product recalled?
Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).
Which agency issued this recall?
This recall was issued by the FDA Drug on June 13, 2018. Severity: Low. Recall number: D-0876-2018.